• education
Search

Carbotrap

Carbotrap

acarbose

Manufacturer:

Fahrenheit
Concise Prescribing Info
Contents
Acarbose
Indications/Uses
Additional therapy in association w/ diet in patients w/ DM.
Click to view Carbotrap detailed prescribing information
Dosage/Direction for Use
Initially 50 mg 3 times daily or ½ of 100-mg tab 3 times daily. Subsequently, two 50-mg tab 3 times daily or 100 mg 3 times daily up to two 100-mg 3 times daily. May be increased after 4-8 wk.
Click to view Carbotrap detailed prescribing information
Overdosage
View Carbotrap overdosage for action to be taken in the event of an overdose.
Administration
Should be taken with food: Take immediately before or during meals. Swallow whole w/ some liqd.
Contraindications
Hypersensitivity. Chronic intestinal disorders associated w/ distinct digestion & absorption disturbances. Inflammatory bowel disease. Severe renal impairment (CrCl <25 mL/min). Pregnancy & lactation. Patient <18 yr.
Click to view Carbotrap detailed prescribing information
Special Precautions
Monitor liver function during 1st 6-12 mth of therapy.
Click to view Carbotrap detailed prescribing information
Adverse Reactions
Flatulence; diarrhea, GI & abdominal pain.
Click to view Carbotrap detailed prescribing information
Drug Interactions
Decrease in blood glucose values w/ sulphonylurea, metformin & insulin. May affect bioavailability w/ digoxin. Simultaneous administration of cholestyramine, intestinal absorbents & digestive enzyme products should be avoided. Loss of glucose control w/ diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, OCs, phenytoin, nicotinic acid, sympathomimetics & INH. Reduction of post prandial blood glucose w/ neomycin.
Click to view Carbotrap detailed prescribing information
Storage
View Carbotrap storage conditions for details to ensure optimal shelf-life.
Description
View Carbotrap description for details of the chemical structure and excipients (inactive components).
Action
View Carbotrap mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Antidiabetic Agents
ATC Classification
A10BF01 - acarbose ; Belongs to the class of alpha glucosidase inhibitors. Used in the treatment of diabetes.
Presentation/Packing
Form
Carbotrap tab 100 mg
Packing/Price
3 × 10's
Form
Carbotrap tab 50 mg
Packing/Price
3 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in